HHS kidney plan sets priorities, but changes no care rules now

The Department of Health and Human Services’ Kidney Care National Plan sets three priorities for future federal work: preventing kidney failure, expanding choice and competition in dialysis, and reforming the transplant system. Announced Oct. 20, 2026, the strategy describes actions agencies may pursue; it does not itself change screening requirements, dialysis rules, coverage or payment rates.

The scale of the health issue is substantial. HHS estimates that 37 million U.S. adults have chronic kidney disease and says 87% of them do not know they have it. Applying that rounded percentage to HHS’s estimate gives about 32 million adults who may be unaware—a calculation, not a separate HHS count.

HHS also reports that about 831,000 people were living with kidney failure in 2023, while about 90,000 people were on the transplant waiting list. These figures describe different groups: kidney failure may require dialysis or a transplant, while the waiting-list number counts people seeking a transplant.

Screening, dialysis and transplant priorities i

For prevention, HHS says agencies will consider an evidence review of screening for people at elevated risk, including those with diabetes, high blood pressure, cardiovascular disease, or a family history of kidney failure or rare kidney disease. The strategy also points to possible prevention-focused payment models and research or treatment pathways aimed at earlier diagnosis and care. These are proposed areas of work, not new screening instructions for patients or clinicians.

For dialysis, HHS proposes examining facility certification and requirements, home-based treatment, alternative care settings, and barriers facing new providers and technologies. The department says two companies control roughly 74% of the dialysis market and argues that market concentration and regulation can limit competition and innovation. That is HHS’s policy rationale; the plan does not establish that its proposed steps have changed the market.

HHS cites an existing increase in home dialysis: its share rose from 10.5% in 2017 to 16% in 2023. That is a gain of 5.5 percentage points, or about 52% relative to the 2017 share. The figures show a trend that predates the 2026 strategy, not an effect of it. HHS also reports that kidney transplants increased 24% between 2019 and 2023.

For transplantation, HHS identifies possible work on modernizing transplant technology, including multi-vendor contracting; stronger oversight of organ-procurement organizations; faster certification for new organizations; and support for living donation. The fact sheet describes actions for agencies to consider, rather than completed changes to transplant procedures.

What the strategy means for patients now i

Does the plan change what patients must do or what care is covered now? No. It sets federal priorities but creates no immediate screening mandate, dialysis requirement, transplant rule, coverage change or new payment rate. The National Kidney Foundation welcomed the focus on prevention, patient choice and transplantation, while saying implementation still lies ahead.

HHS says agencies will use the strategy to pursue future policy, payment, research, regulatory and oversight work. The department has not set a binding timetable in its announcement. HHS also cited up to $4.67 million for a KidneyX prize competition; that is separate from the plan, which the National Kidney Foundation says creates no new funding commitment.